0512.HK HKSE
Grand Pharmaceutical Group Limited
1W: -0.6%
1M: -1.2%
3M: -10.9%
YTD: -39.2%
1Y: -41.8%
3Y: +20.3%
5Y: -16.4%
HK$4.73 ($0.60)
-0.07 (-1.46%)
Weekly Expected Move ±3.9%
HK$4
HK$5
HK$5
HK$5
HK$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$27.2B
+8.7% ▲
5Y CAGR: +9.8%
Total Liabilities
$9.9B
+16.7% ▲
5Y CAGR: +11.9%
Shareholders Equity
$17.0B
+3.3% ▲
5Y CAGR: +8.6%
Cash & Investments
$2.1B
-33.5% ▼
5Y CAGR: -2.6%
Total Debt
$4.7B
+6.3% ▲
5Y CAGR: +14.6%
Net Debt
$3.6B
+14.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.8B | $1.4B | $1.3B | $1.3B | $1.2B |
| Short-Term Investments | $1.1B | $1.0B | $1.1B | $1.8B | $924M |
| Cash & ST Investments | $2.9B | $2.5B | $2.5B | $3.1B | $2.1B |
| Net Receivables | $2.1B | $2.2B | $2.3B | $2.8B | $4.7B |
| Inventory | $1.1B | $1.3B | $1.4B | $1.4B | $1.5B |
| Other Current Assets | $0 | $31M | $106M | $136M | $0 |
| Total Current Assets | $6.8B | $6.9B | $7.0B | $8.0B | $8.3B |
| Property, Plant & Equip. | $3.8B | $3.9B | $4.0B | $3.8B | $4.8B |
| Goodwill & Intangibles | $2.2B | $2.7B | $2.2B | $3.8B | $4.9B |
| Long-Term Investments | $8.4B | $8.4B | $8.4B | $6.2B | $8.0B |
| Other Non-Current Assets | -$131M | $385M | $845M | $3.0B | $1.0B |
| Total Non-Current Assets | $14.3B | $15.5B | $15.5B | $17.0B | $18.9B |
| Total Assets | $21.1B | $22.4B | $22.5B | $25.0B | $27.2B |
| — Liabilities — | |||||
| Accounts Payable | $734M | $873M | $1.3B | $1.2B | $1.8B |
| Short-Term Debt | $2.1B | $3.2B | $2.3B | $3.1B | $2.8B |
| Deferred Revenue | $202M | $319M | $198M | $0 | $324M |
| Other Current Liabilities | $2.2B | $1.6B | $1.5B | $2.0B | $2.1B |
| Total Current Liabilities | $5.6B | $6.5B | $5.7B | $6.6B | $7.3B |
| Long-Term Debt | $1.5B | $1.2B | $990M | $1.3B | $1.8B |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $2.0B | $1.7B | $1.5B | $1.9B | $2.6B |
| Total Liabilities | $7.6B | $8.2B | $7.2B | $8.5B | $9.9B |
| — Equity — | |||||
| Common Stock | $35M | $35M | $35M | $35M | $35M |
| Retained Earnings | $5.9B | $7.5B | $8.9B | $10.3B | $0 |
| Accumulated OCI | $935M | $104M | -$122M | -$242M | $0 |
| Total Stockholders Equity | $13.4B | $14.1B | $15.2B | $16.5B | $17.0B |
| Total Liabilities & Equity | $21.1B | $22.4B | $22.5B | $25.0B | $27.2B |
| — Key Metrics — | |||||
| Total Debt | $3.6B | $4.5B | $3.4B | $4.4B | $4.7B |
| Net Debt | $1.9B | $3.0B | $2.1B | $3.1B | $3.6B |
| Total Investments | $9.5B | $9.5B | $9.5B | $8.0B | $8.9B |